Rate My Professor Mark Habgood

In addition to his research, Habgood coordinates units at Monash University, including Translational Medicine (TRM6008) and Clinical and Translational Neuroscience (TRM5005). He has produced 33 research outputs from 1991 to 2025, including 28 articles, 2 letters, 2 review articles, and 1 comment or debate contribution. Key publications include: "Effects of valproate on the entry of inert hydrophilic markers and expression of tight junction associated genes in the neonatal brain and choroid plexus of a rat model of epilepsy (GAERS)" (2025, Fluids and Barriers of the CNS); "Gestational Valproate Exposure Induces Tissue-Specific Transcriptomic Changes in the Neonatal Brain and Choroid Plexus in a Rat Model of Epilepsy, GAERS" (2025, European Journal of Neuroscience); "Paracetamol, its metabolites, and their transfer between maternal circulation and fetal brain in mono- and combination therapies" (2025, Pharmacological Reports); "ABC Efflux Transporters and Solute Carriers in the Early Developing Brain of a Marsupial Monodelphis domestica (South American Gray Short-Tailed Opossum)" (2024, Journal of Comparative Neurology); and "Effects of co-administration of lamotrigine on valproate transfer across the placenta and its brain entry in developing Genetic Absence Epilepsy Rats from Strasbourg (GAERS)" (2024, European Journal of Neuroscience). His work supports UN Sustainable Development Goals 3 (Good Health and Well-being) and 13 (Climate Action). Professional identifiers include ORCID 0000-0003-4227-5769 and Scopus ID 6701312558.